NCT02445703View on ClinicalTrials.gov

Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

301

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

June 30, 2016

Conditions
Hepatitis AHepatitis B
Interventions
BIOLOGICAL

Inactivated Hepatitis A vaccine (HAV)

Dosage of HAV is 250u hepatitis A antigen/0.5ml/dose.

BIOLOGICAL

Combined hepatitis A and hepatitis B vaccine (HABV)

Dosage of HABV is 250u hepatitis A antigen and 5µg hepatitis B antigen/0.5ml/dose

Trial Locations (1)

410005

Hunan Provincial Center for Disease Control and Prevention, Changsha

All Listed Sponsors
lead

Sinovac Biotech Co., Ltd

INDUSTRY

NCT02445703 - Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine | Biotech Hunter | Biotech Hunter